ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

BeOne Medicines clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 195 studies whose lead sponsor is BeOne Medicines or the company grouped under it. 51 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare BeOne Medicines with AbbVie and Eli Lilly →

Pipeline: 24 programs

Each counted once: 24 with a study BeOne Medicines leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 6 with the most live studies.

Program
sonrotoclaxPhase 3 · 13 live · Leukemia, Lymphocytic, Chronic, B-Cell · primary completion Nov 2026☆ Track
tislelizumabPhase 3 · 9 live · Carcinoma, Non-Small-Cell Lung · primary completion Nov 2026☆ Track
tacabrutidegPhase 3 · 7 live · Leukemia, Lymphocytic, Chronic, B-Cell · primary completion Nov 2026☆ Track
Anti-GPC3/Anti-4-1BB Bispecific Antibody BGB-B2033Phase 3 · 3 live · Carcinoma, Hepatocellular · primary completion Mar 2027☆ Track
CDK4 Inhibitor BGB-43395Phase 3 · 2 live · Breast Neoplasms · primary completion Nov 2026☆ Track

1 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of BeOne Medicines’ own registered studies; BeOne Medicines’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of BeOne Medicines’ programs has a dated deal behind it: 1 brought in. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 1

What it is testing

The drugs BeOne Medicines’ studies test, most open studies first — 31 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 31; every drug is on its own page, and each page lists its sponsors.

Coming up

23 of BeOne Medicines’ studies under way reach primary completion within a year, 4 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 5N’26
  2. 3D
  3. J’27
  4. 1F
  5. 2M
  6. A
  7. 1M
  8. 2J
  9. 3J
  10. A
  11. 1S
  12. 3O
  13. 2N

The 12 nearest

Show 7 more

Add all 23 to your calendar (.ics) → With an account.

All 195 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now5126%Recruiting 40 · Not yet recruiting 11
  • Under way, not recruiting1910%
  • Completed10353%
  • Stopped early2111%Terminated 18 · Withdrawn 3
  • Status unknown or other11%

Phase

Where

Over the years

  1. 13
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. 19
  8. 20
  9. 21
  10. 22
  11. 23
  12. 24
  13. 25
  14. 2526

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to BeOne Medicines.

  • BeiGene
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    125 studies
  • BeOne Medicines
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    69 studies
  • BeiGene USA, Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions BeOne Medicines leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 195. Browse all 195 →